Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clinical Study to Evaluate the Pharmacokinetics and Safety of BDP HFA Nasal Aerosol

This study has been completed.
Information provided by (Responsible Party):
Teva Pharmaceutical Industries Identifier:
First received: February 15, 2012
Last updated: February 22, 2012
Last verified: February 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2009
  Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):